This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2002 Mar 1;20(5):1161-3.

doi: 10.1200/JCO.2002.20.5.1161.

Recurrent ovarian cancer: evidence-based treatment

PMID: 11870155
DOI: 10.1200/JCO.2002.20.5.1161

Editorial

Recurrent ovarian cancer: evidence-based treatment

Robert F Ozols. J Clin Oncol. 2002.

. 2002 Mar 1;20(5):1161-3.

doi: 10.1200/JCO.2002.20.5.1161.

Author

PMID: 11870155
DOI: 10.1200/JCO.2002.20.5.1161

No abstract available

PubMed Disclaimer

Comment on

Retrospective analysis of carboplatin and paclitaxel as initial second-line therapy for recurrent epithelial ovarian carcinoma: application toward a dynamic disease state model of ovarian cancer.
Dizon DS, Hensley ML, Poynor EA, Sabbatini P, Aghajanian C, Hummer A, Venkatraman E, Spriggs DR. Dizon DS, et al. J Clin Oncol. 2002 Mar 1;20(5):1238-47. doi: 10.1200/JCO.2002.20.5.1238. J Clin Oncol. 2002. PMID: 11870166

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information